Pharmacoeconomic analysis of cost-benefit in evaluating the effectiveness of treatment for epilepsy in adults
The investigation evaluated the clinicoeconomic benefits of epilepsy therapy performed by a district neurologist versus an epileptologist in the outpatient setting. The index «cost-benefit» was calculated for different types of epileptic seizures in employed and unemployed patients before and after...
Main Authors: | P. N. Vlasov, N. V. Orekhova, M. V. Leonova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2010-06-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/44 |
Similar Items
-
THE STRUCTURE OF COSTS OF ANTIEPILEPTIC THERAPY ACCORDING TO THE DATA OF CENTER FOR CHILDREN WITH EPILEPSY
by: E. V. Shagrova, et al.
Published: (2015-07-01) -
Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy
by: Sudhir C. Sarangi, et al.
Published: (2020-10-01) -
Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults
by: D. Yu. Belousov, et al.
Published: (2018-06-01) -
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT
by: N. K. Mazina, et al.
Published: (2016-04-01) -
Pharmacoeconomic analysis of perampanel for resistance partial epilepsy
by: D. Yu. Belousov, et al.
Published: (2018-06-01)